Partnerships & Global Reach
Knowledge Advanced Through Rigorous Dialogue
The Center cultivates rigorous scientific and intellectual collaborations with leading universities, scientific institutions, and cultural organizations, enabling its concepts and theories to be studied, tested, developed, and applied across diverse civilizational contexts.
Institutional Approach
Scholarly Principles & Intellectual Attribution
The Center explores pathways for international collaboration and global dialogue on the future of leadership, humanity, and cognition in the age of artificial intelligence. Research partnerships are explicitly structured to advance empirical testing, curriculum development, and applied governance while maintaining transparent intellectual attribution for the foundational theories, models, and original treatises created by Founder Dr. Abdulmohsen Hameed Alrohaimi.
Charter of Academic Integrity
REF: MOU-ALR-2026All collaborative protocols uphold international academic peer-review standards and recognized intellectual attribution conventions to ensure scholarly rigor.
Partnership Tracks
Collaboration Typologies
Tailored engagement frameworks connecting the Center with universities, national agencies, and international bodies.
Academic Research Partnerships
Collaborative empirical research with universities and scientific institutes to test Alrohaimi Theory, calibrate transformation metrics, and mentor emerging fellows.
Knowledge & Cultural Collaboration
Strategic alliances with cultural entities to co-publish scholarly reference works, translate foundational treatises, and host symposia.
Global Dialogue on Human Futures
High-level international assemblies convening thought leaders to examine the future of human agency and conscious leadership in the algorithmic era.
Affiliated Sovereign Initiatives
AI for Drug Innovation Ecosystem (WAII)
Supervisory Authority
SDAIA (Saudi Data & AI Authority)
Monsha'at License
LICENSE NO. 1171
NCENP Non-Profit Reg
NO. 1000706000
A sovereign national initiative spearheaded by Dr. Abdulmohsen Alrohaimi (Chairman of the Board), synthesizing scientific research, advanced AI, and accelerated biopharmaceutical discovery. Operating under the technical supervision of SDAIA and running a specialized accelerator licensed by Monsha'at (No. 1171), the ecosystem transforms laboratory discoveries into investable therapeutic assets.
AI Drug Innovation Accelerator (Monsha'at License No. 1171)
A specialized sovereign platform designed to accelerate drug innovation through artificial intelligence, transforming lab research into investable assets. The accelerator operates innovation hubs and dedicated lab facilities across Saudi universities and medical centers.
The 6-Stage Acceleration Pathway:
Scientific Assessment
Defining scientific rigor, IP strength, and market readiness.
AI & Tech Development
Enhancing proprietary AI models and biomedical datasets.
Validation & Benchmarking
Testing scientific and technical readiness in certified labs.
Intellectual Property
Structuring patent architecture and licensing agreements.
Commercialization
Forming spin-offs, licensing models, and commercial routes.
Investment Readiness
Connecting founders with strategic capital and health funds.
What Do We Accept?
- Advanced research projects & Proof of Concept
- AI models and domain-specific LLMs
- Pharmaceutical patents & biotech prototypes
- Emerging health-tech & biotech startups
Expected Institutional Outcomes
- Licensed university spin-off companies
- Joint patents & licensing commercialization
- Deep-tech capability building for Saudi talent
- Attracting domestic & global venture capital
Accelerator Operational Framework
ISSUED BY MONSHA'AT · LICENSE #1171 · RIYADH
Global Corridors
Global Intellectual Dialogue Nodes
Epistemic corridors connecting Riyadh to leading global academic capitals and research hubs.
Riyadh · Center Headquarters
Collaborative Research Agenda: Global Headquarters & Intellectual Origin
Partner With Us
Submit a Partnership Proposal
If your institution seeks to collaborate on research, pilot diagnostic frameworks, or host joint leadership cohorts, please submit the details below.